| Year |
Citation |
Score |
| 2022 |
Bose M, Grover P, Sanders AJ, Zhou R, Ahmad M, Shwartz S, Lala P, Nath S, Yazdanifar M, Brouwer C, Mukherjee P. Overexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal Adenocarcinoma. Frontiers in Cell and Developmental Biology. 10: 821875. PMID 35237602 DOI: 10.3389/fcell.2022.821875 |
0.681 |
|
| 2021 |
Sahraei M, Bose M, Sanders JA, De C, DasRoy L, Nath S, Brouwer CR, Mukherjee P. Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models. International Journal of Molecular Sciences. 22. PMID 34070449 DOI: 10.3390/ijms22115587 |
0.683 |
|
| 2019 |
Curry JM, Besmer DM, Erick TK, Steuerwald N, Das Roy L, Grover P, Rao S, Nath S, Ferrier JW, Reid RW, Mukherjee P. Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice. Plos One. 14: e0224309. PMID 31693710 DOI: 10.1371/Journal.Pone.0224309 |
0.776 |
|
| 2018 |
Grover P, Nath S, Nye MD, Zhou R, Ahmad M, Mukherjee P. SMAD4-independent activation of TGF-β signaling by MUC1 in a human pancreatic cancer cell line. Oncotarget. 9: 6897-6910. PMID 29467938 DOI: 10.18632/Oncotarget.23966 |
0.671 |
|
| 2017 |
Grover P, Nye MD, Yazdanifar M, Ahmad M, Zhou R, Roy LD, Grover K, Wu S, Nath S, Mukherjee P. Abstract 321: MUC1 regulates TGFβ function in pancreatic cancer Cancer Research. 77: 321-321. DOI: 10.1158/1538-7445.Am2017-321 |
0.661 |
|
| 2016 |
Devi GR, Nath S. Delivery of Synthetic mRNA Encoding FOXP3 Antigen into Dendritic Cells for Inflammatory Breast Cancer Immunotherapy. Methods in Molecular Biology (Clifton, N.J.). 1428: 231-43. PMID 27236803 DOI: 10.1007/978-1-4939-3625-0_15 |
0.504 |
|
| 2016 |
Nath S, Devi GR. Three-dimensional culture systems in cancer research: Focus on tumor spheroid model. Pharmacology & Therapeutics. PMID 27063403 DOI: 10.1016/J.Pharmthera.2016.03.013 |
0.494 |
|
| 2016 |
Evans MK, Sauer SJ, Nath S, Robinson TJ, Morse MA, Devi GR. X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity. Cell Death & Disease. 7: e2073. PMID 26821068 DOI: 10.1038/Cddis.2015.412 |
0.412 |
|
| 2015 |
Nath S, Roy LD, Grover P, Rao S, Mukherjee P. Mucin 1 Regulates Cox-2 gene in Pancreatic Cancer. Pancreas. PMID 26035123 DOI: 10.1097/Mpa.0000000000000371 |
0.699 |
|
| 2015 |
Grover P, Nath S, Ahmad M, Mukherjee P. Abstract 2054: In pancreatic cancer, MUC1 regulates function of TGF-β and thus enhances metastasis Cancer Research. 75: 2054-2054. DOI: 10.1158/1538-7445.Am2015-2054 |
0.706 |
|
| 2014 |
Nath S, Bhowmick S, Dutta T, Chowrasia VR, Bhattacharya S, Chatterjee RN, Sarkar M, Ram AK, Mukherjee PK. A study of promotional advertisements of drugs in a medical journal: an ethics perspective. Indian Journal of Medical Ethics. 11: 237-41. PMID 25377037 DOI: 10.20529/IJME.2014.059 |
0.484 |
|
| 2014 |
Nath S, Mukherjee P. MUC1: a multifaceted oncoprotein with a key role in cancer progression. Trends in Molecular Medicine. 20: 332-42. PMID 24667139 DOI: 10.1016/J.Molmed.2014.02.007 |
0.724 |
|
| 2014 |
Kidiyoor A, Schettini J, Besmer DM, Rego SL, Nath S, Curry JM, Roy LD, Dréau D, Mukherjee P. Pancreatic Cancer Cells Isolated from Muc1-Null Tumors Favor the Generation of a Mature Less Suppressive MDSC Population. Frontiers in Immunology. 5: 67. PMID 24605110 DOI: 10.3389/Fimmu.2014.00067 |
0.774 |
|
| 2013 |
Nath S, Daneshvar K, Roy LD, Grover P, Kidiyoor A, Mosley L, Sahraei M, Mukherjee P. MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes. Oncogenesis. 2: e51. PMID 23774063 DOI: 10.1038/oncsis.2013.16 |
0.633 |
|
| 2013 |
Curry JM, Besmer DM, Roy LD, Grover P, Nath S, Rao S, Mukherjee P. Abstract 475: Combinational treatment with MUC1 vaccine and Indomethacin reduces breast tumor burden via a COX-independent pathway. Cancer Research. 73: 475-475. DOI: 10.1158/1538-7445.Am2013-475 |
0.758 |
|
| 2013 |
Nath S, Roy LD, Rao S, Grover P, Mukherjee P. Abstract 3119: MUC1 transcriptionally regulates COX-2 gene in pancreatic cancer cells. Cancer Research. 73: 3119-3119. DOI: 10.1158/1538-7445.Am2013-3119 |
0.748 |
|
| 2012 |
Sahraei M, Roy LD, Curry JM, Teresa TL, Nath S, Besmer D, Kidiyoor A, Dalia R, Gendler SJ, Mukherjee P. MUC1 regulates PDGFA expression during pancreatic cancer progression. Oncogene. 31: 4935-45. PMID 22266848 DOI: 10.1038/Onc.2011.651 |
0.788 |
|
| 2012 |
Nath S, Daneshvar K, Puri N, Mukherjee P. Abstract LB-348: Chemoresistance in pancreatic cancer is conferred by MUC1 cytoplasmic tail binding to the promoter region of the ABCC1 (MRP-1) gene Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-348 |
0.694 |
|
| 2012 |
Besmer D, Kidiyoor A, Nath S, Roy LD, Curry J, Mukherjee P. Abstract 5400: Investigating the role of IDO in MUC1 expressing breast cancers Cancer Research. 72: 5400-5400. DOI: 10.1158/1538-7445.Am2012-5400 |
0.793 |
|
| 2011 |
Roy LD, Sahraei M, Subramani DB, Besmer D, Nath S, Tinder TL, Bajaj E, Shanmugam K, Lee YY, Hwang SI, Gendler SJ, Mukherjee P. MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition. Oncogene. 30: 1449-59. PMID 21102519 DOI: 10.1038/Onc.2010.526 |
0.775 |
|
| 2011 |
Nath S, Rao S, Tinder TL, Gendler S, Mukherjee P. Abstract 2910: Oncogenic role of MUC1 in context of TGF-β production and signaling Cancer Research. 71: 2910-2910. DOI: 10.1158/1538-7445.Am2011-2910 |
0.694 |
|
| Show low-probability matches. |